Notably, restoring CTLA-4 function through Abatacept—a fusion protein of IgG1 with the extracellular domain of CTLA-4—has been proven effective in immune dysregulation in CVID [124,125] (section Treatment). Here, CTLA4 is linked to common variable immunodeficiency.